• 1
    DeWys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69:491498.
  • 2
    Costa G, Lane WW, Vincent RG, Siebold JA, Aragon M, Bewley PT. Weight loss and cachexia in lung cancer. Nutri Cancer 1981; 2:98103.
  • 3
    Freeman M, Frankmann C, Beck J, Valdivieso M. Prognostic nutrition factors in lung cancer patients. J Parent Ent Nutr 1982; 6:122127.
  • 4
    Pareria ME, Conrad EJ, Hicks W, Elman R. Clinical response and changes in nitrogen balance, body weight, plasma proteins and hemoglobin following tube feeding in cancer cachexia. Cancer 1955; 8:803808.
  • 5
    Terepka AR, Waterhouse C. Metabolic observations during forced feeding of patients with cancer. Am J Med 1956; 20:235238.
  • 6
    Aker SN. Oral feedings in the cancer patient. Cancer 1979; 43:21032107.
  • 7
    Block JB, Chlebowski RT, Herrold JN. Continuous enteric alimentation with a blenderized formula in cancer cachexia. Clin Oncol 1981; 7:9398.
  • 8
    Copeland EM, Macfayden BV, Dudrick SJ. Effect of hyperalimentation on established delayed hypersensitivity in the cancer patient. Ann Surg 1976; 184:6064.
  • 9
    Issel BF, Valdievieso M, Zaren HA et al. Protection against chemotherapy toxicity by IV hyperalimentation. Cancer Treat Rep 1978; 62:11391143.
  • 10
    Popp MB, Fisher RI, Wesley R et al. A prospective, randomized study of adjuvant parenteral nutrition in the treatment of advanced diffuse lymphoma: Influence on survival. Surgery 1981; 90:195202.
  • 11
    Levine AS, Brennan MF, Ramu A, Fisher RI, Pizzo PA, Glaubiger DL. Controlled clinical trials of nutritional intervention as an adjuvant to chemotherapy, with a comment on nutrition and drug resistance. Cancer Res 1982; 42:774s781s.
  • 12
    Nixon DW, Moffitt S, Lawson DH et al. Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treat Rep 1981; 65:121128.
  • 13
    Jordan WM, Valdievieso M, Frankmann C et al. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive IV hyperalimentation. Cancer Treat Rep 1981; 65:197205.
  • 14
    Samuels ML, Selig DE, Ogden S et al. IV hyperalimentation and chemotherapy for Stage II testicular cancer: a randomized study. Cancer Treat Rep 1981; 68:615627.
  • 15
    Brennan MF. Total parenteral nutrition in the cancer patient. N Engl J Med 1981; 305:375382.
  • 16
    Copeland EM. Intravenous hyperalimentation and chemotherapy: An update. J Parent Ent Nutr 1982; 6:236239.
  • 17
    Darbinian JA, Coulston AM. Parenteral nutrition in cancer therapy: A useful adjunct? J Am Dietetic Assoc 1983; 82:493498.
  • 18
    Chlebowski RT, Heber D, Block JB. Lung cancer cachexia. In: GrecoFA, ed. Biology and Management of Lung Cancer. Boston: Martinus Nijhoff Publishers, 1983; 125142.
  • 19
    Valdievieso M, Bodey GP, Benjamin RS et al. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep 1981; 65 (Suppl 5): 145150.
  • 20
    Serrou B, Cupissol D, Plagne R et al. Follow-up of a randomized trial for rat cell carcinoma evaluating the efficacy of peripheral intravenous nutrition (PIVN) as adjunct treatment. Recent Results Cancer Res 1982; 80:246253.
  • 21
    Donaldson SS, Wesley MN, Ghavimi F et al. A prospective randomized clinical trial of total parenteral nutrition in children with cancer. Med Pediatr Oncol 1982; 10:129139.
  • 22
    Van Eys J, Copeland EM, Cangir A et al. A randomized controlled clinical trial of hyperalimentation in children with metastatic malignancies. Med Pediatr Oncol 1980; 8:6373.
  • 23
    Brennan MF. Uncomplicated starvation versus cancer cachexia. Cancer Res 1977; 37:23592362.
  • 24
    Bennegard K, Eden E, Ekman L, Schersten T, Lundholm K. Metabolic response of whole body and peripheral tissues to enteral nutrition in weight-losing cancer and non-cancer patients. Gastroenterology 1983; 85:9299.
  • 25
    Muller JM, Dienst C, Brenner U, Pichlmaier H. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet 1982; 1:6871.
  • 26
    Williams RHP, Heatley RV, Lewis MH, Hughes LE. A randomized controlled trial of preoperative intravenous nutrition in patients with stomach cancer. Br J Surg 1976; 63:667671.
  • 27
    Silberman H. Critical evaluation of the role of nutritional support before surgery in improving postoperative outcome. Cancer (In press).
  • 28
    Meguid MM. Indications for nutritional support after surgery in the patient with cancer. Cancer (In press).
  • 29
    de Vries EG, Mulder MH, Houwen B, de Vries-Hospers HG. Enteral nutrition by nasogastric tube in adult patients treated with intensive chemotherapy for acute leukemia. Am J Clin Nutr 1982; 35:14901496.
  • 30
    Hays DM, Merritt RJ, White L, Ashley J, Siegel SE. Effect of total parenteral nutrition in marrow recovery during induction therapy for acute nonlymphocytic leukemia in childhood. Med Pediatr Onc 1983; 11:134140.
  • 31
    Popp MB, Wagner SC, Brito OJ. Host and tumor responses to increasing levels of intravenous nutritional support. Surgery 1983; 92:300307.
  • 32
    Buzby GP, Mullen JL, Stein TP, Miller EE, Hobbs CI, Rosato EF. Host-tumor interaction and nutrient supply. Cancer 1980; 45:29402948.
  • 33
    Goodgame JTJR, Lowry SF, Brennan MF. Nutritional manipulations and tumor growth: II. The effects of intravenous feeding. Am J Clin Nutr 1979; 32:22852294.
  • 34
    Kishi T, Iwasawa Y, Hirosh I, Chibata J. Nutritional responses of tumor-bearing rats to oral or intravenous feeding. J Parent Ent Nutr 1982; 6:295299.
  • 35
    Cameron IL. Effect of total parenteral nutrition on tumor-host responses in rats. Cancer Treat Rep 1981; 65 (Suppl 5): 9399.
  • 36
    Daly JM, Reynolds HM, Rowlands BJ, Dudrick SJ, Copeland EM III. Tumor growth in experimental animals. Nutritional manipulation and chemotherapeutic response in the rat. Ann Surg 1983; 191:316322.
  • 37
    Torosian MH, Mullen JL, Miller EE, Wagner KM, Stein TP, Buzby GP. Adjuvant, pulse total parenteral nutrition and tumor response to cycle-specific and cycle nonspecific chemotherapy. Surgery 1983; 93:291299.
  • 38
    Fenninger LD, Mider GB. Energy and nitrogen metabolism in cancer. Adv Cancer Res 1954; 2:229532.
  • 39
    Chlebowski RT, Heber D. Hypogonadism in male patients with metastatic cancer prior to treatment. Cancer Res 1982; 42:24952498.
  • 40
    Theologides A. Pathogenesis of cachexia in cancer. Cancer 1972; 8:84488488.
  • 41
    Greenway B, Iqbal MJ, Johnson PJ, Williams R. Low serum testosterone concentrations in patients with carcinoma of the pancreas. Br Med J 1983; 286:9395.
  • 42
    Recchione C, Galante E, Secreto G, Cavalleri A, Dati V. Abnormal serum hormone levels in lung cancer. Tumori 1983; 69:293398.
  • 43
    Chiavina YD, Tyutyunova AM, Chilingaryants SG. Correlation between the conditions of steroid balance and survival times of radically operated lung cancer patients. Vopr Onkol 1983; 29:4650.
  • 44
    Chlebowski RT, Herrold J, Richardson B, Block JB. Effects of decadurabolin in patients with advanced non-small cell lung cancer. Clin Res 1982; 23:541.
  • 45
    Edelstyn GA, Macrae KD, MacDonald FM. Improvement of life quality in cancer patients undergoing chemotherapy. Clin Oncol 1979; 5:4349.
  • 46
    Spiers ASD, DeVita SF, Allar MJ, Richards S, Sedransk N. Beneficial effects of an anabolic steroid during cytostatic chemotherapy for metastatic cancer. J Med 1981; 12:433442.
  • 47
    Lelli G, Angelelli B, Giambiasi ME et al. The anabolic effect of high dose medoxyprogesterone acetate in oncology. Pharm Res Com 1983; 15:561568.
  • 48
    Rohdenburg GL, Bernhard A, Krehbiel O. Sugar tolerance in cancer. JAMA 1919; 72:15281529.
  • 49
    Holyroyde CP, Reichard GA. Carbohydrate metabolism in cancer cachexia. Cancer Treat Rep 1982; 65:5559.
  • 50
    Chlebowski RT, Heber D, Block JB. Serial assessment of glucose metabolism in patients with cancer cachexia. Clin Res 1982; 30:69A.
  • 51
    Lundholm K, Edstrom S, Karlberg I, Ekman L, Schersten T. Glucose turnover, gluconeogenesis from glycerol and estimation of net glucose cycling in cancer patients. Cancer 1982; 50:11421150.
  • 52
    Heber D, Chlebowski RT, Ishibashi DE, Herrold JN, Block JB. Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients. Cancer Res 1982; 42:48154819.
  • 53
    Gold J. Cancer cachexia and gluconeogenesis. Ann NY Acad Sci 1979; 230:103110.
  • 54
    Schien PS, Kisner D, Haller D, Blecher M, Hamosh M. Cachexia of malignancy: Potential role of insulin in nutritional management. Cancer 1979; 43:20702076.
  • 55
    Ray PD, Hanson RL, Lardy HA. Inhibition by hydrazine of gluconeogenesis in rat. J. Biol Chem 1970; 245:690696.
  • 56
    Gershanovich ML, Filov VA. Hydrazine sulfate in late stage cancer: completion of initial clinical trials in 225 evaluable patients. Proc Am Assoc Cancer Res 1979; 20:240.
  • 57
    Gold J. Use of hydrazine sulfate in terminal and pre-terminal cancer patients: Results of investigational new drug (IND) study in 84 evaluable patients. Oncology 1975; 32:110.
  • 58
    Lerner HJ, Regelson W. Clinical trial of hydrazine sulfate in solid tumors. Cancer Treat Rep 1976; 60:959960.
  • 59
    Spremulli E, Wampler GL, Regelson W. Clinical study of hydrazine sulfate in advanced cancer patients. Cancer Chemotherm Pharm 1979; 3:121124.
  • 60
    Chlebowski RT, Heber D, Richardson B, Block JB. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss. Cancer Res 1984; 44:857861.
  • 61
    Chlebowski RT, Heber D, Richardson B et al. Association between improved carbohydrate metabolism and weight maintenance in hydrazine sulfate treated patients with cancer cachexia. Proc Am Assoc Clin Oncol 1983; 2: C-372.
  • 62
    Nixon DW. Hyperalimentation in the undernourished cancer patient. Cancer Res 1982; 42 (Suppl): 727s728s.
  • 63
    Mashburn LT, Robertson JT. Diet therapy as a supplement to surgery and radiation for treatment of gliomas. Proc Am Assoc Cancer Res 1982; 23:550.